U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000083: Acute Otitis Media Severity of Symptoms Scale (AOM-SOS)
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000083: Acute Otitis Media Severity of Symptoms Scale (AOM-SOS)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Infectious Diseases (OID)
Division of Anti-Infectives (DAI)

DDT COA Number
DDT COA #000083

Instrument Name
Acute Otitis media Severity of Symptoms Scale (AOM-SOS)

Disease/Condition
Acute otitis media

Concept of Interest
acute otitis media symptoms

Context of Use
Children with acute otitis media

COA Type
ObsRO

Qualification Stage
Letter of Intent-Accepted

Requestor(s)
Nader Shaikh
Alejandro Hoberman

Contact(s)
Nader Shaikh

Date Accepted into CDER’s COA Qualification Program
November 16, 2015

Submission and Regulatory Correspondence History

Qualification Submission

Date

FDA Submission Decision & Recommendations

Date

--

--

Transition Letter to 507 Process

9/5/19

Back to Top